MedTrace Logo

Mental Health Among Patients, Providers, and Staff During the COVID-19 Era

NCT04700137 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 666

Last updated 2024-01-25

Study results available
· View outcomes & findings →

Summary

The Mental Health Among Patients, Providers, and Staff (MHAPPS) Study is designed to study how the COVID-19 pandemic has affected mental health and wellbeing, and how to support mental health while minimizing the burden on the healthcare system. The study will enroll adults and adolescents who have had a primary care visit in the last 12 months, as well as healthcare providers and staff from a large health system in Idaho.

The study will include:

Aim 1: a cross sectional survey to measure the prevalence of various measures of mental distress and how they are associated with COVID-19-related factors; and

Aim 2: a randomized controlled trial comparing the effectiveness of two versions of a Caring Contacts intervention to reduce loneliness and mental distress.

Conditions

Interventions

OTHER

Caring Contacts Plus Introductory Phone Call (CC+)

One introductory semi-structured caring phone conversation with a follow-up specialist to check-in, establish a personal connection, and provide resources at the 0-2 week time-point followed by 11 non-demanding, caring text or email messages sent over the course of 6 months.

OTHER

Caring Contacts without an introductory phone call (CC)

Eleven non-demanding, caring text or email messages sent over the course of 6 months. Participants will not know or have spoken to the follow-up specialist who sends the caring messages.

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Idaho Crisis & Suicide Hotline

    collaborator OTHER

  • University of Washington

    collaborator OTHER

  • St. Luke's Health System, Boise, Idaho

    lead OTHER

Principal Investigators

  • Anna K Radin, DrPH, MPH · St. Luke's Health System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-18
Primary Completion
2022-01-06
Completion
2022-01-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04700137 on ClinicalTrials.gov